Publicação: Efficacy and safety of an additional 8 weeks of tofacitinib induction therapy: Updated results of the OCTAVE Open study for tofacitinib 8-week induction non-responders
dc.contributor.author | Rubin, D. T. | |
dc.contributor.author | Dubinsky, M. C. | |
dc.contributor.author | Danese, S. | |
dc.contributor.author | Saad-Hossne, R. [UNESP] | |
dc.contributor.author | Ponce de Leon, D. | |
dc.contributor.author | Maller, E. | |
dc.contributor.author | Lawendy, N. | |
dc.contributor.author | Kwok, K. | |
dc.contributor.author | Su, C. | |
dc.contributor.institution | Univ Chicago Med | |
dc.contributor.institution | Icahn Sch Med Mt Sinai | |
dc.contributor.institution | Humanitas Res Hosp | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.contributor.institution | Pfizer Inc | |
dc.date.accessioned | 2020-12-11T11:00:41Z | |
dc.date.available | 2020-12-11T11:00:41Z | |
dc.date.issued | 2020-01-01 | |
dc.description.affiliation | Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA | |
dc.description.affiliation | Icahn Sch Med Mt Sinai, Dept Pediat & Med, New York, NY 10029 USA | |
dc.description.affiliation | Humanitas Res Hosp, Dept Gastroenterol, IBD Ctr, Milan, Italy | |
dc.description.affiliation | Sao Paulo State Univ, Botucatu Med Sch, IBD Grp, Sao Paulo, Brazil | |
dc.description.affiliation | Pfizer Inc, Lima, Peru | |
dc.description.affiliation | Pfizer Inc, Collegeville, PA USA | |
dc.description.affiliation | Pfizer Inc, New York, NY USA | |
dc.description.affiliationUnesp | Sao Paulo State Univ, Botucatu Med Sch, IBD Grp, Sao Paulo, Brazil | |
dc.format.extent | S537-S538 | |
dc.identifier.citation | Journal Of Crohns & Colitis. Oxford: Oxford Univ Press, v. 14, p. S537-S538, 2020. | |
dc.identifier.issn | 1873-9946 | |
dc.identifier.uri | http://hdl.handle.net/11449/197693 | |
dc.identifier.wos | WOS:000518803402236 | |
dc.language.iso | eng | |
dc.publisher | Oxford Univ Press | |
dc.relation.ispartof | Journal Of Crohns & Colitis | |
dc.source | Web of Science | |
dc.title | Efficacy and safety of an additional 8 weeks of tofacitinib induction therapy: Updated results of the OCTAVE Open study for tofacitinib 8-week induction non-responders | en |
dc.type | Resumo | |
dcterms.license | http://www.oxfordjournals.org/access_purchase/self-archiving_policyb.html | |
dcterms.rightsHolder | Oxford Univ Press | |
dspace.entity.type | Publication | |
unesp.campus | Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu | pt |
unesp.department | Cirurgia e Ortopedia - FMB | pt |